Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Clinical Trial

Randomized Controlled Trial

Clinical Trial, Phase II

Case Reports

Research Support, U.S. Gov't, P.H.S.

Observational Study

Research Support, N.I.H., Extramural

Multicenter Study

Publication Year

From

Quick links

Individual year

2024

2023

2022

2021

2018

2017

2014

2013

2012

2008

2005

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Thymidine Phosphorylase""[mesh_terms]

18 Results

Searching titles within these results

CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Michio Hirano, Caterina Garone, Catarina M Quinzii

Biochimica et biophysica acta 2012;1820(5):625-31

Free Full Text

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network.

Michio Hirano, Francesco Nonino, Roberto De Giorgio, Elisa Boschetti, Valerio Carelli, Loris Pironi, Anna Accarino, Giovanna Cenacchi, Roberto D'Alessandro, Massimiliano Filosto, Ramon Martí, Antonio Daniele Pinna, Elisa Baldin, Bridget Elizabeth Bax, Alessio Bolletta, Riccardo Bolletta, Matteo Cescon, Roberto D'Angelo, Maria Teresa Dotti, Carla Giordano, Laura Ludovica Gramegna, Michelle Levene, Raffaele Lodi, Hanna Mandel, Maria Cristina Morelli, Olimpia Musumeci, Alessia Pugliese, Mauro Scarpelli, Antonio Siniscalchi, Antonella Spinazzola, Galit Tal, Javier Torres-Torronteras, Luca Vignatelli, Irina Zaidman, Heinz Zoller, Rita Rinaldi, Massimo Zeviani

Journal of inherited metabolic disease 2021;44(2):376-387

Free Full Text

Abstract

Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction.

Jixiang Du, Chao Zhang, Fuchen Liu, Xihan Liu, Dongdong Wang, Dandan Zhao, Guanghou Shui, Yuying Zhao, Chuanzhu Yan

Journal of molecular medicine (Berlin, Germany) 2023;101(10):1237-1253

Full Text

Abstract

Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.

Qianqian Feng, Wei Yang, Zhiyun Peng, Guangcheng Wang

European journal of pharmacology 2022;934():175319

Full Text

Abstract

Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE).

Francisca Joly, Bernard Flourié, Bernard Messing, Jacqueline Mikol, Hugues Blondon, Marc Polivka

Gastroenterologie clinique et biologique 2005;29(8-9):773-8

Free Full Text

Abstract

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?

Marco Tampellini, Paolo Bironzo, Massimo Di Maio, Giorgio V Scagliotti

Future oncology (London, England) 2018;14(12):1223-1231

Full Text

Abstract

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.

J P Braybrooke, D J Propper, K J O'Byrne, M I Koukourakis, A V Patterson, S Houlbrook, S D Love, S Varcoe, M Taylor, T S Ganesan, D C Talbot, A L Harris

British journal of cancer 2000;83(2):219-24

Free Full Text

Abstract

Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients.

M Kurosumi, T Tabei, K Suemasu, K Inoue, T Kusawake, N Sugamata, Y Higashi

Oncology reports 2001;7(5):945-8

Full Text

Abstract

Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4.

Bin Wang, Yun Song, Jian Wu, Tianye He, Bicui Chen, Yaqun Li, Biyu Xiong, Jianfei Long

European journal of clinical pharmacology 2024;80(7):1029-1038

Full Text

Abstract

Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.

M Ohi, C Miki

Scandinavian journal of gastroenterology 2000;35(4):413-8

Full Text

Abstract

The use of capecitabine in the combined-modality therapy for rectal cancer.

Bruce D Minsky, Stanley L Liauw

Clinical colorectal cancer 2008;7(2):99-104

Full Text

Abstract

Role of angiogenesis in the development and growth of liver metastasis.

Akihiko Takeda, Oliver Stoeltzing, Syed A Ahmad, Niels Reinmuth, Wenbiao Liu, Alexander Parikh, Fan Fan, Morihisa Akagi, Lee M Ellis

Annals of surgical oncology 2002;9(7):610-6

Full Text

Abstract

Taxanes and capecitabine in combination: rationale and clinical results.

James F Maher, Miguel A Villalona-Calero

Clinical breast cancer 2002;2(4):287-93

Full Text

Abstract

Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).

Takeo Mori, Masayuki Ohue, Yasumasa Takii, Tadashi Hashizume, Tomoyuki Kato, Kenjiro Kotake, Toshihiko Sato, Toshiro Tango

Oncology reports 2013;29(2):437-44

Full Text

Abstract

Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.

Keiji Koda, Hideaki Miyauchi, Chihiro Kosugi, Takashi Kaiho, Nobuhiro Takiguchi, Susumu Kobayashi, Takashi Maruyama, Hisahiro Matsubara

Anticancer research 2017;36(10):5325-5331

Full Text

Abstract

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Thymidine Phosphorylase""[mesh_terms]

CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network.

Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction.

Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.

Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE).

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.

Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients.

Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4.

Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer.

The use of capecitabine in the combined-modality therapy for rectal cancer.

Role of angiogenesis in the development and growth of liver metastasis.

Taxanes and capecitabine in combination: rationale and clinical results.

Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).

Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.

Results for
""Thymidine Phosphorylase""[mesh_terms]